According to Custom Market Insights (CMI), the Global Breast Cancer Detection Market size was estimated at USD 5 Billion in 2021 and is expected to hit around USD 7.5 Billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 6% from 2022 to 2030.
Our research report offers a 360-degree view of the Breast Cancer detection market’s drivers and restraints, coupled with the impact they have on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Breast Cancer Detection market.
Breast Cancer Detection Market: Overview
One of the most prevalent cancers in the world and a major factor in the death of women is breast cancer. So, in order to treat breast cancer disorders, early detection is necessary. Due to their modern lifestyles, industrialized nations have a higher prevalence of breast cancer, while undeveloped nations have a higher incidence rate. According to the World Health Organization, 2.3 million women worldwide had a breast cancer diagnosis in 2020, and there were 685,000 breast cancer-related deaths.
Browse the full “Breast Cancer Diagnostics Market Size, Trends, and Insights By Type (Imaging, Genomic Tests, Biopsy, Blood Tests, Others), By Product (Platform-based Products, Next-generation Sequencing, PCR, Microarrays, Others, Instrument-based Products, Biopsy, Imaging), By Application (Screening, Prognostic, Diagnostic and Predictive, Research), By End-use (Diagnostic Centers and Medical Laboratories, Hospitals & Clinics, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030 “ report at https://www.custommarketinsights.com/report/breast-cancer-diagnostics-market/
Growth Factors
The growth of global breast cancer detection is largely due to the aging population’s increased exposure to breast cancer risk, early detection, and growing public awareness of breast cancer.
The market expansion is aided by the advent of 3D mammography, also referred to as digital breast tomosynthesis, which is more accurate than 2D mammography. Compared to 2D mammography, this cutting-edge technology can detect 40.0% more tumors while requiring fewer patient recalls. In the anticipated period, the market is predicted to be driven in large part by the quick advancement of technology.
The expansion of the breast cancer Detection market is responsible for the rising number of breast cancer cases in women around the world. Additionally, the market is expanding as a result of rising government initiatives, advantageous reimbursement policies, and growing technological use. Additionally, increasing public awareness has a favorable effect on the market.
Segmental Overview
The market for Breast Cancer Detection is segmented into type, product, application, and end-use. In 2021, the imaging category, which accounted for the biggest revenue share of around 70%, dominated the market for breast cancer Detection. The market is expected to be driven by factors including the high number of procedures, ease of accessibility, and improved efficacy. Mammography, ultrasound, and MRI are the three imaging techniques used most frequently for screening and diagnosis. In addition, the development of a number of cutting-edge imaging methods for the diagnosis of breast cancer, including breast tomosynthesis, molecular breast imaging (MBI), CT, and PET, are anticipated to transform the field of breast imaging.
The market for breast cancer Detection was dominated by the hospitals and clinics sector in 2021, which also had the biggest revenue share of about 50.2%. The segment’s growth is anticipated to be fueled by rising patient hospitalization rates and the burden of disease. Patients receive a biopsy for confirmation testing in hospitals following the screening test. Additionally, PET, CT, and MRI are employed to monitor disease development and evaluate the efficacy of cancer treatment.
Get Free Sample Copy @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=21656
Regional Overview
Due to the rising incidence of breast cancer as well as the adoption of cutting-edge diagnostic methods, the market for breast cancer Detection in the Asia Pacific is anticipated to experience the greatest CAGR over the forecast period. Additionally, it is anticipated that expanding healthcare infrastructure and bettering reimbursement policies will promote market growth.
Competitive Landscape
Companies are using strategies that let them use their resources to improve their supply chain and support the creation of new products.
- 2019: The acquisition of Genomic Health by Exact Sciences Corporation was made public, and it was anticipated that adding Genomic Health’s product line would strengthen the company’s market position and offerings.
Prominent Players
- Hologic Inc.
- Thermo Fisher Scientific Inc.
- BD
- Genomic Health (Exact Sciences Corporation)
- Danaher
- Koninklijke Philips N.V.
- QIAGEN
- Myriad Genetics
- Hoffmann-La Roche Ltd.
- Argon Medical Devices Inc.
Buy Now This Premium Report @ https://www.custommarketinsights.com/checkout/?reportid=21656
About Us:
Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. Custom Market Insights provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.
Contact Us:
USA Corporate Office
CMI Consulting LLC
1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702
Sales & Support +1 801 639 9061
Email : [email protected]
Website : https://www.custommarketinsights.com/
About The Author
